Maternal phenylketonuria syndrome

Congenital heart defects, microcephaly, and developmental outcomes

Bobbye Rouse, Reuben Matalon, Richard Koch, Colleen Azen, Harvey Levy, William Hanley, Frederick Trefz, Felix De La Cruz

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: A cohort of women with phenylketonuria (PKU) were selected to explore the impact of phenylalanine (Phe) levels and other factors on congenital heart defects (CHDs), microcephaly, and development of their offspring. Study design: Three hundred fifty-four women with PKU were followed up weekly with diet records, blood Phe levels, and sonograms obtained at 18 to 20 and 32 weeks' gestation. At birth, 413 offspring were examined and followed up at 6 months and annually by means of Bayley Mental Developmental Index and Psychomotor Developmental Index tests at 1 and 2 years. The women had Wechsler Adult Intelligence Scales and DNA testing. Results: Thirty-one offspring had CHDs; of these, 17 also had microcephaly. Mean Phe levels at 4 to 8 weeks' gestation predicted CHDs (P < .0001). An infant with a CHD had a 3-fold risk of having microcephaly when the mother had higher Phe levels (P = .02). The Bayley Mental Developmental Index and Psychomotor Developmental Index scores correlated with both CHDs (P = .037 and .0015, respectively) and microcephaly (P = .0001 for both). No direct relationship to the PKU mutation was found. Conclusion: None of the women whose offspring had CHDs had blood Phe levels in control during the first 8 weeks of gestation. Women with PKU need to be well controlled on a low- phenylalanine diet before conception and throughout pregnancy.

Original languageEnglish (US)
Pages (from-to)57-61
Number of pages5
JournalJournal of Pediatrics
Volume136
Issue number1
StatePublished - 2000
Externally publishedYes

Fingerprint

Maternal Phenylketonuria
Microcephaly
Congenital Heart Defects
Phenylalanine
Phenylketonurias
Pregnancy
Diet Records
Intelligence
Mothers
Parturition
Diet
Mutation
DNA

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Rouse, B., Matalon, R., Koch, R., Azen, C., Levy, H., Hanley, W., ... De La Cruz, F. (2000). Maternal phenylketonuria syndrome: Congenital heart defects, microcephaly, and developmental outcomes. Journal of Pediatrics, 136(1), 57-61.

Maternal phenylketonuria syndrome : Congenital heart defects, microcephaly, and developmental outcomes. / Rouse, Bobbye; Matalon, Reuben; Koch, Richard; Azen, Colleen; Levy, Harvey; Hanley, William; Trefz, Frederick; De La Cruz, Felix.

In: Journal of Pediatrics, Vol. 136, No. 1, 2000, p. 57-61.

Research output: Contribution to journalArticle

Rouse, B, Matalon, R, Koch, R, Azen, C, Levy, H, Hanley, W, Trefz, F & De La Cruz, F 2000, 'Maternal phenylketonuria syndrome: Congenital heart defects, microcephaly, and developmental outcomes', Journal of Pediatrics, vol. 136, no. 1, pp. 57-61.
Rouse, Bobbye ; Matalon, Reuben ; Koch, Richard ; Azen, Colleen ; Levy, Harvey ; Hanley, William ; Trefz, Frederick ; De La Cruz, Felix. / Maternal phenylketonuria syndrome : Congenital heart defects, microcephaly, and developmental outcomes. In: Journal of Pediatrics. 2000 ; Vol. 136, No. 1. pp. 57-61.
@article{afc0191240d64649b8175651e24c4803,
title = "Maternal phenylketonuria syndrome: Congenital heart defects, microcephaly, and developmental outcomes",
abstract = "Objective: A cohort of women with phenylketonuria (PKU) were selected to explore the impact of phenylalanine (Phe) levels and other factors on congenital heart defects (CHDs), microcephaly, and development of their offspring. Study design: Three hundred fifty-four women with PKU were followed up weekly with diet records, blood Phe levels, and sonograms obtained at 18 to 20 and 32 weeks' gestation. At birth, 413 offspring were examined and followed up at 6 months and annually by means of Bayley Mental Developmental Index and Psychomotor Developmental Index tests at 1 and 2 years. The women had Wechsler Adult Intelligence Scales and DNA testing. Results: Thirty-one offspring had CHDs; of these, 17 also had microcephaly. Mean Phe levels at 4 to 8 weeks' gestation predicted CHDs (P < .0001). An infant with a CHD had a 3-fold risk of having microcephaly when the mother had higher Phe levels (P = .02). The Bayley Mental Developmental Index and Psychomotor Developmental Index scores correlated with both CHDs (P = .037 and .0015, respectively) and microcephaly (P = .0001 for both). No direct relationship to the PKU mutation was found. Conclusion: None of the women whose offspring had CHDs had blood Phe levels in control during the first 8 weeks of gestation. Women with PKU need to be well controlled on a low- phenylalanine diet before conception and throughout pregnancy.",
author = "Bobbye Rouse and Reuben Matalon and Richard Koch and Colleen Azen and Harvey Levy and William Hanley and Frederick Trefz and {De La Cruz}, Felix",
year = "2000",
language = "English (US)",
volume = "136",
pages = "57--61",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Maternal phenylketonuria syndrome

T2 - Congenital heart defects, microcephaly, and developmental outcomes

AU - Rouse, Bobbye

AU - Matalon, Reuben

AU - Koch, Richard

AU - Azen, Colleen

AU - Levy, Harvey

AU - Hanley, William

AU - Trefz, Frederick

AU - De La Cruz, Felix

PY - 2000

Y1 - 2000

N2 - Objective: A cohort of women with phenylketonuria (PKU) were selected to explore the impact of phenylalanine (Phe) levels and other factors on congenital heart defects (CHDs), microcephaly, and development of their offspring. Study design: Three hundred fifty-four women with PKU were followed up weekly with diet records, blood Phe levels, and sonograms obtained at 18 to 20 and 32 weeks' gestation. At birth, 413 offspring were examined and followed up at 6 months and annually by means of Bayley Mental Developmental Index and Psychomotor Developmental Index tests at 1 and 2 years. The women had Wechsler Adult Intelligence Scales and DNA testing. Results: Thirty-one offspring had CHDs; of these, 17 also had microcephaly. Mean Phe levels at 4 to 8 weeks' gestation predicted CHDs (P < .0001). An infant with a CHD had a 3-fold risk of having microcephaly when the mother had higher Phe levels (P = .02). The Bayley Mental Developmental Index and Psychomotor Developmental Index scores correlated with both CHDs (P = .037 and .0015, respectively) and microcephaly (P = .0001 for both). No direct relationship to the PKU mutation was found. Conclusion: None of the women whose offspring had CHDs had blood Phe levels in control during the first 8 weeks of gestation. Women with PKU need to be well controlled on a low- phenylalanine diet before conception and throughout pregnancy.

AB - Objective: A cohort of women with phenylketonuria (PKU) were selected to explore the impact of phenylalanine (Phe) levels and other factors on congenital heart defects (CHDs), microcephaly, and development of their offspring. Study design: Three hundred fifty-four women with PKU were followed up weekly with diet records, blood Phe levels, and sonograms obtained at 18 to 20 and 32 weeks' gestation. At birth, 413 offspring were examined and followed up at 6 months and annually by means of Bayley Mental Developmental Index and Psychomotor Developmental Index tests at 1 and 2 years. The women had Wechsler Adult Intelligence Scales and DNA testing. Results: Thirty-one offspring had CHDs; of these, 17 also had microcephaly. Mean Phe levels at 4 to 8 weeks' gestation predicted CHDs (P < .0001). An infant with a CHD had a 3-fold risk of having microcephaly when the mother had higher Phe levels (P = .02). The Bayley Mental Developmental Index and Psychomotor Developmental Index scores correlated with both CHDs (P = .037 and .0015, respectively) and microcephaly (P = .0001 for both). No direct relationship to the PKU mutation was found. Conclusion: None of the women whose offspring had CHDs had blood Phe levels in control during the first 8 weeks of gestation. Women with PKU need to be well controlled on a low- phenylalanine diet before conception and throughout pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0033941662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033941662&partnerID=8YFLogxK

M3 - Article

VL - 136

SP - 57

EP - 61

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -